Anthony Brade

4.1k total citations
105 papers, 2.8k citations indexed

About

Anthony Brade is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Anthony Brade has authored 105 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 38 papers in Oncology and 31 papers in Radiation. Recurrent topics in Anthony Brade's work include Lung Cancer Diagnosis and Treatment (43 papers), Lung Cancer Treatments and Mutations (33 papers) and Advanced Radiotherapy Techniques (31 papers). Anthony Brade is often cited by papers focused on Lung Cancer Diagnosis and Treatment (43 papers), Lung Cancer Treatments and Mutations (33 papers) and Advanced Radiotherapy Techniques (31 papers). Anthony Brade collaborates with scholars based in Canada, United States and New Zealand. Anthony Brade's co-authors include Andrea Bezjak, A. Sun, Andrew Hope, John Cho, Laura A. Dawson, Jolie Ringash, Henry J. Klamut, Mojgan Taremi, John Kim and James D. Brierley and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer.

In The Last Decade

Anthony Brade

105 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Brade Canada 31 1.3k 811 699 699 524 105 2.8k
Jeffrey Meyer United States 23 790 0.6× 713 0.9× 621 0.9× 557 0.8× 511 1.0× 125 2.3k
Changhu Chen United States 22 1.1k 0.8× 658 0.8× 696 1.0× 481 0.7× 328 0.6× 40 3.0k
Giuseppe Roberto D’Agostino Italy 30 1.1k 0.8× 512 0.6× 669 1.0× 396 0.6× 104 0.2× 125 2.4k
David Shultz Canada 24 899 0.7× 231 0.3× 547 0.8× 429 0.6× 116 0.2× 136 2.1k
Gregory S. Sibley United States 19 1.5k 1.1× 976 1.2× 460 0.7× 999 1.4× 116 0.2× 41 2.6k
Henrik Roed Denmark 22 525 0.4× 463 0.6× 755 1.1× 342 0.5× 229 0.4× 56 1.8k
Cinzia Pettinato Italy 24 1.1k 0.9× 113 0.1× 509 0.7× 892 1.3× 199 0.4× 60 2.8k
Paul B. Romesser United States 25 865 0.6× 342 0.4× 958 1.4× 397 0.6× 77 0.1× 112 2.7k
Yee‐Min Jen Taiwan 24 540 0.4× 206 0.3× 366 0.5× 244 0.3× 308 0.6× 70 1.9k
Thomas Zilli Switzerland 28 1.9k 1.4× 791 1.0× 408 0.6× 847 1.2× 54 0.1× 182 2.7k

Countries citing papers authored by Anthony Brade

Since Specialization
Citations

This map shows the geographic impact of Anthony Brade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Brade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Brade more than expected).

Fields of papers citing papers by Anthony Brade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Brade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Brade. The network helps show where Anthony Brade may publish in the future.

Co-authorship network of co-authors of Anthony Brade

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Brade. A scholar is included among the top collaborators of Anthony Brade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Brade. Anthony Brade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Melosky, Barbara, Mark Vincent, Anna McGuire, et al.. (2024). Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer. International Journal of Cancer. 155(6). 963–978. 3 indexed citations
3.
Melosky, Barbara, Rosalyn A. Juergens, Deanna McLeod, et al.. (2019). Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer. Lung Cancer. 134. 259–267. 30 indexed citations
4.
Lim, Chétana, Harman Sekhon, Jean-Claude Cutz, et al.. (2017). Improving Molecular Testing and Personalized Medicine in Non-Small-Cell Lung Cancer in Ontario. Current Oncology. 24(2). 103–110. 29 indexed citations
5.
McPartlin, Andrew, Patricia Lindsay, James D. Brierley, et al.. (2016). Dosimetric Associations With Acute Liver Toxicity in Stereotactic Body Radiation Therapy for Liver Metastases. International Journal of Radiation Oncology*Biology*Physics. 96(2). E201–E202. 2 indexed citations
6.
Brade, Anthony, Robert M. MacRae, Scott A. Laurie, et al.. (2015). Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non–Small Cell Lung Cancer. Clinical Lung Cancer. 17(2). 133–141. 8 indexed citations
7.
Brade, Anthony, Sylvia S. W. Ng, James D. Brierley, et al.. (2015). Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 94(3). 580–587. 87 indexed citations
8.
Reiss, Kim A., Joseph M. Herman, Marianna Zahurak, et al.. (2014). A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis. Clinical Cancer Research. 21(1). 68–76. 58 indexed citations
9.
Taremi, Mojgan, Andrea Bezjak, Anthony Brade, et al.. (2013). The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(5). 1064–1070. 108 indexed citations
10.
Mehta, Minesh P., Walter J. Curran, Ding Wang, et al.. (2012). Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases.. Journal of Clinical Oncology. 30(15_suppl). 2013–2013. 14 indexed citations
11.
Lim, Gerald, Andrea Bezjak, Jane Higgins, et al.. (2011). Tumor Regression and Positional Changes in Non-small Cell Lung Cancer During Radical Radiotherapy. Journal of Thoracic Oncology. 6(3). 531–536. 54 indexed citations
12.
Coate, Linda, Christine Massey, Andrew Hope, et al.. (2011). Treatment of the Elderly When Cure is the Goal: The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(3). 537–544. 44 indexed citations
13.
You, Benoît, Anthony Brade, Lillian L. Siu, et al.. (2010). A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies. Investigational New Drugs. 29(5). 996–1003. 23 indexed citations
15.
Bezjak, Andrea, Thomas G. Purdie, Mojgan Taremi, et al.. (2009). Intrafractional Target Position Accuracy for Lung Stereotactic Body Radiotherapy (SBRT) using Cone-beam CT (CBCT). International Journal of Radiation Oncology*Biology*Physics. 75(3). S160–S161. 3 indexed citations
16.
Hope, Andrew, Max Dahele, K. Franks, et al.. (2009). Chest Wall Pain and Rib Fracture after Stereotactic Radiotherapy for Peripheral Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(8). 1035–1037. 71 indexed citations
17.
Dahele, Max, Anthony Brade, Shannon Pearson, & Andrea Bezjak. (2009). Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer. Canadian Medical Association Journal. 180(13). 1326–1328. 11 indexed citations
18.
Dahele, Max, Shannon Pearson, Thomas G. Purdie, et al.. (2008). Practical Considerations Arising from the Implementation of Lung Stereotactic Body Radiation Therapy (SBRT) at a Comprehensive Cancer Center. Journal of Thoracic Oncology. 3(11). 1332–1341. 34 indexed citations
20.
Wong, J. Tze‐Fei, Ayeda Ayed, Anthony Brade, et al.. (2000). Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression. Journal of Biological Chemistry. 275(26). 20127–20135. 235 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026